CryoLife Inc. (NYSE:CRY) shares are down today after the medical device maker yesterday reported third-quarter results that missed expectations. The Atlanta-area company posted profits of $1.6 million, or 4¢ per share, on sales of $64.6 million for the three months ended Sept. 30, for a bottom-line gain of 18.1% on sales growth of 46.8% compared […]
Featured
Teleflex tops The Street with Q3 numbers
Teleflex (NYSE:TFX) reported third-quarter numbers today that topped the consensus on Wall Street and raised its earnings outlook for the rest of the year, sending share prices up in early trading despite a large profit slide. The Wayne, Pa.-based medical device company reported profits of $56.5 million, or $1.21 per share, on sales of $609.7 million […]
Integer gains on Q3 sales, earnings beats, raises outlook
Integer Holdings (NYSE:ITGR) share prices rose today after the contract manufacturer posted third-quarter results that handily beat the consensus forecast, powered by a whopping 733.3% bottom-line gain. Plano, Texas-based Integer reported profits of $114.1 million, or $3.54 per share, on sales of $305.1 million for the three months ended Sept. 28, for top-line growth of 6.6% […]
Intuitive doesn’t expect any Chinese expanded quota da Vinci Sales this year
Intuitive Surgical (NSDQ:ISRG) said yesterday that despite the Chinese National Health Commission publishing a new quota expansion looking to add more surgical robots over the next two years, it does not expect to sell any systems under the new quota this year. Sunnyvale, Calif.-based Intuitive Surgical saw shares rise over 5% yesterday on the news that […]
Abiomed shreds fiscal Q2 forecasts
Abiomed (NSDQ:ABMD) today posted fiscal second-quarter numbers that shredded the consensus forecast and raised its outlook on the rest of the year, sending share prices up sharply today. The Danvers, Mass.-based cardiac assist device maker more than doubled its profits to $50.1 million, or $1.09 per share, on sales of $181.8 million, for a 104.6% […]
Reva launches Fantom Encore bioresorbable scaffold
Reva Medical (ASX:RVA) said this week that it launched its Fantom Encore bioresorbable, drug-eluting scaffold and that the first person was treated in a post-market trial of the device. The Fantom Encore product is a third-gen coronary bioresorbable scaffold featuring a thin strut profile and Reva’s Tyrocore polymer. Get the full story at our sister site, […]
Smith & Nephew up on Q3 sales gain
Investors pushed share prices for Smith & Nephew (NYSE:SNN) up in London and New York today after the medical device giant posted a third-quarter revenue gain and confirmed its outlook for the rest of the year. The British orthopedics and wound care firm reported that sales grew 1.5% to $1.15 billion during the three months […]
FDA clears Zimmer Biomet’s Persona knee implant
Zimmer Biomet (NYSE:ZBH) said today that the FDA granted 510(k) clearance for its Persona revision knee implant. Warsaw, Ind.-based Zimmer said the Persona system is designed to match each patient’s unique anatomy with customized components. “The clearance of the Persona revision knee system gives us the ability to provide surgeons with a full service portfolio for […]
Fresenius posts shrinking sales, profits in Q3
Fresenius (NYSE:FMS) shares have stayed steady today after the company released third quarter earnings that saw profits and sales shrink compared to the previous year. The Bad Homburg, Germany-based company posted profits of $322.6 million (EU €285 million), or $1.05 per share (EU €0.93), on sales of approximately $4.6 billion (EU €4.1 billion) for the three […]
Intuitive Surgical shares rise on expanded surgical robot quota in China
Intuitive Surgical (NSDQ:ISRG) shares have risen over 5% in pre-market trading after the Chinese government released a new Large-Scale Medical Equipment Configuration Plan calling for an additional 154 surgical robot systems to be deployed in the country by the end of 2020. The official release from the Chinese Government calls for a total of 197 endoscopic […]
Axonics prices upsized $120m offering
Axonics Modulation Technologies yesterday priced an upsized initial public offering that could fetch a maximum of $138 million. Irvine, Calif.-based Axonics, which makes the r-SNM device sacral neuromodulation system for treating overactive bladder, fecal incontinence and urinary retention, last week set the range for the flotation at $93.3 million to $106.7 million, saying it would issue nearly 6.7 million shares […]
